Clinical Trial: Neoadjuvant Immunochemotherapy Combined with Surgery for Locally Advanced, Intermediate-Risk Oral Cancer: A Prospective, Multicenter, Randomized Phase III Clinical Trial Comparing Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy (China)

China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Neoadjuvant Immunochemotherapy Combined with Surgery for Locally Advanced, Intermediate-Risk Oral Cancer: A Prospective, Multicenter, Randomized Phase III Clinical Trial Comparing Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132094

Registration Time: 2026/09/09

Type: Interventional study

Primary Sponsor: Hunan Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=287416

Published by HT Digital Content Services with permission from Health Daily Digest....